MaaT Pharma Stock OTC Markets
Stocks
MATPF
FR0012634822
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| Market Cap | 52.67M 60.59M 49.02M 45.01M 85M 5.78B 86.31M 578M 227M 2.88B 228M 223M 9.65B | P/E 2026 * |
-1.46x | P/E 2027 * | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 63.97M 73.59M 59.54M 54.67M 103M 7.02B 105M 702M 275M 3.5B 276M 270M 11.73B | EV / Sales 2026 * |
6.56x | EV / Sales 2027 * | 3.02x |
| Free-Float |
36.85% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: MaaT Pharma
| Manager | Title | Age | Since |
|---|---|---|---|
Hervé Affagard
CEO | Chief Executive Officer | - | 01/01/2014 |
Eric Soyer
DFI | Director of Finance/CFO | 59 | 01/11/2024 |
| Chief Tech/Sci/R&D Officer | - | 24/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Hervé Affagard
BRD | Director/Board Member | - | 01/01/2014 |
| Director/Board Member | 57 | 01/01/2014 | |
| Chairman | - | 01/01/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 60.64M | |
| +2.35% | +0.77% | +29.92% | +85.38% | 55.23B | |
| -0.21% | -7.38% | +25.34% | +63.02% | 53.75B | |
| -2.12% | +1.61% | -15.56% | -16.63% | 23.48B | |
| -3.26% | -8.11% | -8.42% | +344.75% | 22B | |
| +2.49% | -1.27% | +15.99% | -10.53% | 19.78B | |
| +0.79% | -1.06% | +29.29% | -33.32% | 17.44B | |
| +0.58% | -7.23% | +24.50% | +519.07% | 14.66B | |
| -4.74% | -3.81% | +47.05% | +170.22% | 14.07B | |
| +3.41% | -7.83% | +161.76% | +284.91% | 13.02B | |
| Average | -0.05% | -1.43% | +34.43% | +156.32% | 25.94B | |
| Weighted average by Cap. | +0.21% | +0.09% | +27.49% | +120.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.75M 11.22M 9.08M 8.33M 15.74M 1.07B 15.98M 107M 41.99M 533M 42.12M 41.2M 1.79B | 28.88M 33.22M 26.88M 24.68M 46.6M 3.17B 47.32M 317M 124M 1.58B 125M 122M 5.29B |
| Net income | -31.69M -36.46M -29.5M -27.08M -51.15M -3.48B -51.94M -348M -136M -1.73B -137M -134M -5.81B | -15.31M -17.61M -14.25M -13.08M -24.71M -1.68B -25.09M -168M -65.93M -837M -66.15M -64.69M -2.81B |
| Net Debt | 11.3M 13M 10.52M 9.66M 18.24M 1.24B 18.53M 124M 48.68M 618M 48.84M 47.76M 2.07B | 34.5M 39.69M 32.11M 29.48M 55.67M 3.79B 56.54M 379M 149M 1.89B 149M 146M 6.32B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MAAT Stock
- MATPF Stock
Select your edition
All financial news and data tailored to specific country editions
